Pfizer Announces Positive Phase 3 CREST Trial Results for Sasanlimab in High-Risk Non-Muscle Invasive Bladder Cancer

Clinically meaningful and statistically significant results are the first pivotal Phase 3 data for sasanlimab, a subcutaneously administered PD-1...

January 13, 2025 | Monday | News
Naveris Expands Commercial Availability of NavDx Test for HPV-Positive Anal Cancer, Enhancing MRD Detection

Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the expanded commercial availability of the NavDx ...

January 13, 2025 | Monday | News
Kardigan Launches with $300 Million Series A to Transform Cardiovascular Disease Treatment

Company embarks on a vision to make cardiovascular disease curable, preventable, and no longer the leading cause of death worldwide Led by found...

January 13, 2025 | Monday | News
QIAcuity Digital PCR Expands Capacity to 12 Targets Simultaneously with New Software Update and High Multiplex PCR Kit

  QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold inc...

January 13, 2025 | Monday | News
Danaher Partners with Innovaccer to Advance Precision Medicine with AI-Enabled Diagnostics

Partnership seeks to improve patient outcomes and experience through novel digital and diagnostic solutions. Investment aligns with Danaher's mission ...

January 10, 2025 | Friday | News
SciSparc Secures Renewal to Advance SCI-210 Clinical Trial for Autism Spectrum Disorder

SciSparc, a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, to...

January 02, 2025 | Thursday | News
Viracta Therapeutics Initiates Strategic Review and Halts NAVAL-1 Trial to Conserve Resources

Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancer...

December 27, 2024 | Friday | News
Japan Approves VYVDURA® for At-Home Self-Injection in gMG and CIDP, Setting a Global Benchmark

VYVDURA® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP argenx's VYVGART® and VYVDURA portfoli...

December 27, 2024 | Friday | News
Proton Intelligence Secures $6.95M Seed Funding to Advance Continuous Potassium Monitoring for Cardio-Kidney-Metabolic Care

Proton Intelligence Inc., developing the first-ever Continuous Potassium Monitoring (CKM™) platform,  announced the closing of its $6.95 milli...

December 26, 2024 | Thursday | News
HKBU and Shanghai Sixth People's Hospital Pioneer Breakthrough Treatment for Rare Bone Disease XLH

A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao ...

December 23, 2024 | Monday | News
Smith+Nephew Expands CORI◊ Surgical System Portfolio with FDA-Cleared CORIOGRAPH Pre-Op Planning for Hip Arthroplasty

Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for patients and surgeons Smith+Nephew (LSE:SN, NYSE:SNN),...

December 20, 2024 | Friday | News
Shaping Biopharma Purification: Phenomenex’s Vision for 2025

Matt Boag, Biopharmaceutical Product Marketing Manager at Phenomenex, discusses the transformative innovations shaping plasmid DNA, mRNA, and peptide purif...

December 12, 2024 | Thursday | Opinion
Advancing Healthspan for All: Dr. Mehmood Khan Spotlights Aging Science Trends for 2025

  In an exclusive interview with BioPharma Boardroom, Dr. Mehmood Khan, Chief Executive Officer of Hevolution Foundation, shares insights into the tr...

December 12, 2024 | Thursday | News
Siemens Healthineers and DeepHealth Collaborate to Launch AI-Powered SmartTechnology™ for Enhanced Ultrasound Diagnostics

Siemens Healthineers and DeepHealth have signed a letter of intent to create AI-powered SmartTechnology™ to improve patient experience and operat...

December 02, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close